Inactive Instrument

Company Sanofi SA Nyse

Equities

US80105N1054

Pharmaceuticals

Business Summary

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases);

- human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas;

- consumer health products (12%).

At the end of 2023, the group had 54 production sites throughout the world.

Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).

Sales per Business

EUR in Million2022Weight2023Weight Delta
Biopharma
88.0 %
30,688 71.4 % 37,890 88.0 % +23.47%
Consumer Healthcare
12.0 %
5,080 11.8 % 5,180 12.0 % +1.97%

Sales per region

EUR in Million2022Weight2023Weight Delta
United States
43.0 %
18,275 42.5 % 18,512 43.0 % +1.30%
Rest of the World
26.1 %
8,386 19.5 % 11,254 26.1 % +34.20%
Europe
18.6 %
7,703 17.9 % 8,013 18.6 % +4.02%
China
6.8 %
3,123 7.3 % 2,912 6.8 % -6.76%
France
5.5 %
2,296 5.3 % 2,379 5.5 % +3.61%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 19-08-31
Director of Finance/CFO 59 18-09-30
Chief Tech/Sci/R&D Officer - 16-08-31
Chief Operating Officer 39 21-12-31
Chief Tech/Sci/R&D Officer 51 -
Chief Tech/Sci/R&D Officer 49 23-09-10
Chief Tech/Sci/R&D Officer - 18-12-31
Public Communications Contact - -
Investor Relations Contact - 20-06-30
Human Resources Officer 53 20-07-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 70 14-04-30
Director/Board Member 64 20-05-21
Director/Board Member 52 20-04-27
Director/Board Member 61 13-05-02
Director/Board Member 68 16-04-30
Director/Board Member 66 22-05-02
Director/Board Member 55 21-04-29
Director/Board Member 71 16-05-03
Director/Board Member 58 21-04-30
Director/Board Member 56 21-03-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,264,799,969 1,110,144,426 ( 87.77 %) 13,450,388 ( 1.063 %) 87.77 %

Shareholders

NameEquities%Valuation
L'ORÉAL
9.348 %
118,227,307 9.348 % 11 245 M $
Amundi Asset Management SA (Investment Management)
2.308 %
29,186,744 2.308 % 2 776 M $
Dodge & Cox
1.780 %
22,512,304 1.780 % 2 141 M $
Crédit Mutuel Asset Management SA
1.113 %
14,070,956 1.113 % 1 338 M $
SANOFI
0.9642 %
12,195,470 0.9642 % 1 160 M $
Lyxor International Asset Management SAS
0.5764 %
7,289,777 0.5764 % 693 M $
Predica Prévoyance Dialogue du Crédit Agricole SA (Invt Port)
0.5390 %
6,817,764 0.5390 % 648 M $
Groupe des Assurances du Crédit Mutuel SA
0.5066 %
6,406,902 0.5066 % 609 M $
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.4712 %
5,959,127 0.4712 % 567 M $
OFI Invest Asset Management SA
0.3952 %
4,998,420 0.3952 % 475 M $
NameEquities%Valuation
Dodge & Cox
3.093 %
78,250,193 3.093 % 3 744 M $
Fidelity Management & Research Co. LLC
0.8056 %
20,379,166 0.8056 % 975 M $
Fisher Asset Management LLC
0.5649 %
14,290,391 0.5649 % 684 M $
Boston Partners Global Investors, Inc.
0.5152 %
13,032,746 0.5152 % 624 M $
Merrill Lynch International
0.4056 %
10,260,690 0.4056 % 491 M $
Eaton Vance Management
0.3111 %
7,868,480 0.3111 % 377 M $
Invesco Advisers, Inc.
0.2735 %
6,919,101 0.2735 % 331 M $
BNY Mellon Investment Adviser, Inc.
0.2452 %
6,203,752 0.2452 % 297 M $
BlackRock Investment Management LLC
0.2165 %
5,477,302 0.2165 % 262 M $
Lee Munder Investments Ltd.
0.1844 %
4,663,598 0.1844 % 223 M $

Holdings

NameEquities%Valuation
13,909,587 60.40% 1,445,172,845 $
12,195,470 0.96% 1,159,913,103 $
EUROAPI
29.77%
28,298,074 29.77% 117,897,700 $
4,697,737 7.39% 28,985,037 $
1,919,455 7.30% 6,391,785 $
3,860,600 0.66% 2,633,315 $
29,249 0.12% 546,310 $

Company contact information

Sanofi

46, avenue de la Grande Armée

75017, Paris

+33 1 53 77 40 00

http://www.sanofi.com
address Sanofi SA

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Medical Specialties
Pharmaceuticals: Major
Aventis, Inc.
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Biotechnology